Literature DB >> 17694270

A case of pure red cell aplasia complicated by Evans syndrome.

Yasuhiko Toyokawa1, Isamu Kingetsu, Chiho Yasuda, Jun Yasuda, Ken Yoshida, Daitaro Kurosaka, Akio Yamada.   

Abstract

A 33-year-old woman complaining of severe anemia was admitted to our hospital for polyclonal hyperglobulinemia. She was diagnosed with pure red cell aplasia (PRCA) associated with Evans syndrome. Initially, the presence of human parvovirus B19 (HPV B19) IgM appeared to indicate that the cause of PRCA was HPV B19 infection. Evans syndrome improved with steroid therapy, but PRCA was refractory. Cyclosporine was administered; consequently, the patient markedly recovered from PRCA and was discharged. PRCA complicated by Evans syndrome occurred during the course of polyclonal hyperglobulinemia. The most direct etiology for the onset of PRCA was unclear; however, immunological disorders such as polyclonal hyperglobulinemia, in addition to HPV B19 infection, may have been partly responsible for the etiology of PRCA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694270     DOI: 10.1007/s10165-007-0584-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

Review 1.  A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature.

Authors:  Yasunobu Sekiguchi; Asami Shimada; Hidenori Imai; Mutsumi Wakabayashi; Keiji Sugimoto; Noriko Nakamura; Tomohiro Sawada; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  Double hit: Evans syndrome after malignant thymoma treatment and parvovirus B19 infection.

Authors:  John Xie; Gerard Chaaya; Rachna Jetly-Shridhar; Thomas Stewart Atkinson
Journal:  BMJ Case Rep       Date:  2020-03-18

3.  High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias.

Authors:  Donjete Simnica; Simon Schliffke; Christoph Schultheiß; Nicola Bonzanni; Lorenzo F Fanchi; Nuray Akyüz; Barbara Gösch; Christian Casar; Benjamin Thiele; Janina Schlüter; Ansgar W Lohse; Mascha Binder
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.